## **TRUSTEES’ ANNUAL REPORT** 

## **AND** 

**INDEPENDENTLY EXAMINED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **FOR** 

## **THE INTERNATIONAL CONTINENCE SOCIETY** 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **CONTENTS OF THE TRUSTEES’ ANNUAL REPORT & INDEPENDENTLY EXAMINED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

||**Page**|
|---|---|
|**Trustees’ Annual Report**|**1**|
|**Independent Examiner’s Report**|**18**|
|**Statement of Financial Activities**|**19**|
|**Consolidated Statement of Financial Activities**|**20**|
|**Balance Sheet**|**21**|
|**Consolidated Balance Sheet**|**22**|
|**Statement of Cash Flows**|**23**|
|**Consolidated Statement of Cash Flows**|**23**|
|**Notes to the Financial Statements**|**25**|





**International Continence Society** www.ics.org info@ics.org +44(0)117 944 4881 

## **Reference and Administrative Details of the Charity, its Trustees and Advisors** 

**Company Number** 3589542 **Registered Charity Number** 1074929 **Registered Office** 48 Corn Street, Third Floor, Bristol, BS1 1HQ **Correspondence Address** 48 Corn Street, Third Floor, Bristol, BS1 1HQ **E-mail** info@ics.org 

**Website** www.ics.org 

**Telephone** +44 (0) 117 944 4881 **General Secretary appointed** John Heesakkers, 3 year term began 09/09/22 **Treasurer appointed** Steven Schraffordt Koops, 3 year term began 09/09/22 **Trustees appointed 2023** Hidehiro Kakizaki, appointed 20/10/2023 to be confirmed for 3 year term at 2023 AGM Reappointed for 3 year terms 3 Feb 2023: Marcus Drake, Lori Birder, Enrico Finazzi Agro **Trustees appointed 2022** Elisabetta Costantini, 3 year term began 09/09/2022 Philip Van Kerrebroeck, reappointed for 3 year term **Trustees appointed 2021** Frankie Bates, 3 year term began 20/10/2021 **Trustee term concluded 2023** Manjula Annappa **Company Secretary** Dominic Turner (appointed 20/11/2023) **Independent Examiner** M Bracher of Haines Watts, Bath House, 6-8 Bath Street, Bristol BS1 6HL **Solicitors** Veale Wasbrough Vizards, Orchard Lane, Bristol BS1 5WS **Bankers** NatWest Bank, Filton Bristol Branch, PO Box 182, 4 Church Road, Bristol BS99 5AA **Investment Managers** Crystal Wealth Management LLP Daniel Snowdon Executive Director (extended sick leave from Monday 13 November 2023) Dominic Turner Information Technology Director Ashley Brookes Senior Analyst Programmer (left employment 19 May 2023) Roger Blackmore Flash Developer/Graphics Designer Mairead Corbet Projects and Events Manager Jennifer Ellis Projects and Events Manager (left employment 16 January 2023) Danielle Piotrowski Marketing and Events Coordinator (joined 7 February 2023) Tracy Griffin Administrator and Membership Secretary (part time) Sarah Waters Bookkeeper (self-employed) Sarah Ashworth Bookkeeper (self-employed) 

## Staff 

## ICS Honorary Members 

Peter Caldwell (Deceased) Patrick Bates (Deceased) Pieter Donker (Deceased) Peter Gammelgaard (Deceased) Eric Glen Axel Ingelman-Sundberg (Deceased) Guus Kramer David Rowan (Deceased) Paul Abrams Walter Artibani Jacques Corcos Jo Laycock (Deceased) Sender Herschorn Karl-Erik Andersson Adrian Wagg Linda Cardozo (Deceased) Ted Arnold Sherif Mourad Jerzy Gajewski Helmut Madersbacher Alan Wein David Castro Diaz Katherine Moore 

1 



## **What is the International Continence Society and what does it do?** 

The International Continence Society (ICS) is a membership society for professionals working in the field of incontinence.  Established in 1971. 

The objectives for which the Charity has been established are: 

- To strive to improve the quality of life for people affected by urinary, bowel and pelvic floor disorders by advancing basic and clinical science through education, research, and advocacy. 

- To raise public awareness of both urinary and anal incontinence, and other functional abnormalities, including obstruction and pain, and the fact that it can be corrected, improved or at least better managed, and to enhance the knowledge and skills of health professionals involved in prevention and management of incontinence and thereby to improve the standard of healthcare delivery. 

## **ICS Mission Statement** 

The International Continence Society is a registered charity with a global health focus which strives to improve the quality of life for people affected by urinary, bowel and pelvic floor disorders by advancing basic and clinical science through education, research, and advocacy. 

## **How our activities deliver public benefit** 

Considerable **public benefit** arises from the work of the ICS.  With regard to the general public, significant and often harmful misunderstandings and stigma still surround relevant medical conditions. The ICS works to break down this stigma.  With regard to healthcare professionals, their knowledge and skills are increased, to the benefit of current and future patients, by the dissemination of knowledge and sharing of best practice at events such as the ICS annual international scientific meeting and the workshops and courses it facilitates (many of which are offered for free). The ICS continues to allow free access to the majority of the ICS website to allow non-ICS members to utilise the vast database of incontinence research now held within it.  For those interested in becoming members of the ICS, the membership fee remains affordable and a host of benefits are included. It is in this regard that the ICS Board of Trustees has considered the public benefit. The ICS clearly fits the Charities Act aims of advancement of education and of health or the saving of lives. The ICS has members in over 70 countries and is therefore helping individuals suffering from incontinence related issues on a global level. 

## **Purposes and Aims** 

Scientific knowledge and expertise on incontinence issues is exchanged between the multi-disciplinary medical professionals through the various forums which the ICS provides, including the Annual Scientific Meeting, news articles and publication of research through journals. Best practices from countries with established continence awareness programmes are shared with others who are trying to set up continence programmes within their country, hospital or clinic. With the dissemination of research on incontinence treatment, the direct beneficiaries are the patients of those individuals who are members of the ICS or those who attend our congresses and courses. 

## **Ensuring our work delivers our aims** 

The key objectives for 2023 were to hold a successful annual meeting in Toronto, to maintain the ICS membership at circa 3,000 members, to review and implement a revised investment strategy, and to 

ICS Trustees Report 2023                                                                      2 



continue to support the establishment of the two new ICS open-access journals, _Continence_ and _Continence Reports_ . 

## **The focus of our work** 

Strategic efforts will continue to advance the educational output of the ICS, mainly through the implementation of ICS Live, webinars, increasing content on ICS TV to provide e-learning, and the continued update and production of ICS standardisation reports and other key educational publications. The financial planning and controls for the society will continue to be reviewed to ensure strategies are fit for purpose. 

## **Structure, Governance and Management** 

## Board of Trustees 

The ICS Board of Trustees is required to meet four times a year (twice in person and twice virtually) and is responsible for: 

- The long-term direction of the ICS 

- The development of new projects in line with the charitable aims of the ICS 

- Ensuring the Society’s charitable aims and objectives are met 

- Inspection of the annual accounts 

- Ensuring suitable accounting policies are established and applied consistently 

- Monitoring and reporting the financial position to membership 

- Safeguarding the assets of the Charity and applying them properly 

- Setting pay and remuneration of key management personnel through an annual performance review and formal consideration of a cost of living increase. 

- Ensuring the ICS is operating efficiently and effectively 

- Ensuring proper records and reliable financial information are maintained 

- Establishing the method, policies and procedures for recruitment, appointment, induction and training of new Trustees 

All nominated candidates for Trustee positions will receive documents outlining their duties, responsibilities and any risks pertaining to the role of Trustee. The Nominations Committee will review all candidates for their suitability, prior to their nominations being put to the membership (for first terms of office). 

## Management Structure 

The ICS is a Company Limited by Guarantee governed by Articles of Association, together with regularly updated Bylaws. These reflect the current activities of the Charity. In the event of the company being wound up members are required to contribute an amount not exceeding £1. 

The Directors of the company are also charity trustees for the purposes of charity law. As a UK Registered Charity, the ICS Trustees are ultimately responsible for the Charity and its affairs. However, the ICS has a management structure and Bylaws which ensure that members have sufficient input on all decisions within the ICS. The Board of Trustees reflects the multi-disciplinary aspects of the society. 

Under supervision of the Trustees and the General Secretary in particular, day-to-day management of the Charity, its trading subsidiary and office staff, is delegated to the Executive Director and the Information Technology Director. The Directors are full-time employees and report directly to the Trustees who are ultimately responsible for the management and finances of the ICS. 

ICS Trustees Report 2023                                                                      3 



## ICS Committees 2023 

The following committees  focus on the different aspects of the ICS and through the direction of the Board of Trustees undertake projects to assist the Board to achieve its overall strategy and Charitable aims: 

- ICS Children and Young Adults’ Committee 

- ICS Developing World Committee 

- ICS Education Committee 

- ICS Ethics Committee 

- ICS Neurourology Promotion Committee 

- ICS Nursing Committee 

- ICS Physiotherapy Committee 

- ICS Scientific Committee 

- ICS Standardisation Steering Committee 

- ICS Urodynamics Committee 

A chair for each of the above-mentioned committees is elected by electronic membership ballot, to hold office for three years. Further information about the remit of each committee can be found on the ICS website. 

## Related Parties 

The wholly owned subsidiary Conticom ICS Limited was established to undertake the commercial trading activities of the Charity.  Conticom ICS Limited gift aids its profits to the Charity. 

## Risk Management 

The Trustees have implemented a formal risk management process to assess business risks and implement risk management strategies. 

The Trustees have identified the types of risks the Charity faces, and have prioritised them in terms of potential impact and likelihood of occurrence, and identified, where possible, means of mitigating the risks. The adequacy of internal controls is reviewed and costs of implementing new controls compared to benefits obtained and implemented, if agreed.  Procedures have been established for immediate reporting of failure to appropriate levels of management and to the Board of Trustees. 

The task of monitoring the financial control systems and procedures of the Charity is delegated to the ICS Treasurer (Steven Schraffordt Koops). In conjunction with the Executive Director and the ICS Accountants (Haines Watts Accountants [Bristol] Limited), the Treasurer reviews and reports to the Trustees on the working of these systems and procedures in relation to the wider issue of managing major risks identified as arising from or in connection with the activities of the Charity. 

The Trustees continue to keep under review the adequacy of our systems which are, in our opinion, appropriate for the Charity at present. The reserves policy requires the ICS to retain running costs for two future years plus £100,000 in case of unforeseen liabilities. Please note the further comment on reserves in the financial review section on page 7. 

The Trustees continue to judge that an area of risk requiring particular attention is the ICS Annual Meeting, where possible cancellation or postponement due to terrorist attacks or natural disasters is a major concern. This was particularly felt during 2020 and 2021 due to the COVID-19 pandemic. The 

ICS Trustees Report 2023                                                                      4 



Charity has passed on the major risk to our permanent Congress Organiser (Kenes International) who, from 2008, has borne the financial risk of any cancellation or postponement. The Trustees also ensure that adequate levels of insurance are sought for each event. A risk reduction has been realised through the agreement to host every other annual meeting in Europe. This continent offers the best chance of reaching a sustainable surplus level, from which much of the activity and support costs of the ICS are funded. 

With regard to the Society’s finances, the bookkeeper and accountants are fully aware of the current status and systems used and could take over from the Directors in this regard in an emergency. The General Secretary and the Directors are all signatories to the Society‘s accounts and therefore the accounts can be maintained. 

With regard to IT systems, the IT Director has documented all design and maintenance work to ensure that another IT specialist could take over in an emergency. All systems and the ICS website are backed up and stored off site. 

Wherever possible, ICS office staff are trained and briefed in all office procedures. All email communications are also filed for historical purposes. 

## **Objectives and Activities** 

The strategies employed in the year to achieve the objectives of the Charity were: 

- To host a successful Annual Scientific Meeting, a high quality educational event which will continue to secure the status of the ICS as the premier international multidisciplinary conference in the field of incontinence. 

- To support establishment of the two new open-access journals owned by ICS. 

- To set up and develop new strategic partnerships with individuals and organisations. 

- To maintain the ICS membership at 3,000 or more members. 

- To enable more accessible educational content for our global membership. 

- To continue and consolidate ICS projects and initiatives such as the production of Standardisation reports, the delivery of Educational Courses and the provision of Awards and Fellowships. 

## **Achievements and Performance** 

## **Executive Summary** 

The meeting held in Toronto was challenging in the post Covid environment with increased costs of travel putting pressure on European delegates to attend. In addition the Canadian government visa system delays prevented many delegates from attending. The regulatory framework for industry made Toronto less attractive to our sponsors. Overall the meeting made a loss despite being a successful educational event. Our no loss guarantee protected ICS, however the lack of any generated surplus for 2023 was a major concern. 

ICS recorded 2,760 members for 2023 (2022: 2,859). This reduction is in line with holding our annual meeting outside of Europe. Post covid all our members face increased financial pressures. 

In financial terms the charity closed the year with a deficit position, whereby expenditure in the year was in excess of income. This was largely due to the zero surplus received from the annual meeting. 

ICS Trustees Report 2023                                                                      5 



The board has taken steps including the two new journals to create new streams of revenue in 2024 outside of the annual meeting. 

A new office was found for the ICS Office at 48 Corn Street in central Bristol. A huge amount of work was done to move from the remote working environment to hybrid and getting our office setup. 

## ICS Annual Scientific Meeting 2023 

The ICS Annual Meeting remains the main focus of the ICS and consists of a scientific programme selected from submitted abstracts, along with workshops, courses, committee meetings as well as the ICS Annual General Meeting. 

The 53[rd] Annual Meeting of the ICS returned to an in-person only event.  The meeting was attended by 1,434 delegates from over 60 countries, proved the international appeal of ICS meetings. The total numbers were impacted by visa delays by the Canadian government and the increase in travel and accommodation costs post-Covid. 

The Scientific Committee continued the strategy of providing programme ‘tracks’ to ensure that delegates would always have some content of interest or relevance at any point in the programme. 

Our full thanks go to Magdy Hassouna (Meeting Chair), Jerzy Gajewski and Nucelio Lemos (Local Scientific Programme Chairs) and the whole ICS 2023 local organising committee for their dedicated efforts and commitment. Evaluation scores were highly positive in all categories. Thanks are also due to the ICS office staff, ICS committees and the ICS meeting organiser, Kenes International. 

The wholly owned subsidiary of the Charity, Conticom-ICS Limited, operates the Annual Meeting and the profits are donated to the ICS each year where a surplus has been made. 

## New ICS journals 

Two new journals Continence and Continence Reports continued to grow. The Editors of the journals were respectively, Lori Birder, and Sajjad Rahnama’i. The journals are open-access format to support the new model of journals, and to support the ICS’s charitable goal to grow and share continence education globally. 

## Awards and Fellowships 

The ICS continued to make awards or fellowships available to all ICS members with a view to improving the public benefit in supporting younger or less advantaged persons in their medical/health studies. The ICS offered 8 fellowships covering Urodynamics, Neurourology, Clinical and Research to early career doctors from Bangladesh, Brazil, Canada, Colombia, Ethiopia, Netherlands, Nigeria, Taiwan and the United States. 

## Educational Courses 2023 

During 2023 ICS was able to offer faculty to 16 educational events around the world: 

- Sunday 8th January - Pudenedal Neuropathy: ICS Global Pelvic Pain Exchange Program 

- 2nd - 5th February - USICON 2023 

- 3rd - 5th March - ICS 10th Workshop for Surgical Repair of Vaginal Fistula & Urinary Incontinence 

- Sunday 5th March - Pharmacology for Pain: ICS Global Pelvic Pain Exchange Program 

- Saturday 11th March - ICS Guest Lecture at 38th Annual EAU Congress 

ICS Trustees Report 2023                                                                      6 



- Sunday 16th April - Physiotherapy for Pain: ICS Global Pelvic Pain Exchange Program 

- Friday 5th May - Psychological Aspects of Pain: ICS Global Pelvic Pain Exchange Program 

- 9th - 12th May - 26th Congress of the Iranian Urological Association 

- Sunday 4th June - Rectal / Perianal Pain: ICS Global Pelvic Pain Exchange Program 

- Friday 9th June - ICS Guest Lecture at INUS Annual Congress 2023 

- 15th - 17th June - ICS add-on course at 47th SIUD Congress 

- Wednesday 21st June - ICS Workshop at 2023 IUGA 48th Annual Meeting 

- Friday 23rd June - ICS Guest Lecture at 48th IUGA Annual Meeting 

- 7th - 9th September - 30th Annual Meeting of the Japanese Continence Society 

- 7th - 9th September - 19th Pan Arab Continence Society Conference 2023 

- 21st - 23rd September - Voiding Dysfunctions Summit - September 2023 

- Thursday 28th September - ICS 2023 Late Breaking Abstracts 

- Sunday 15th October - “How-To”: Basic Approaches to Pelvic Pain: ICS Global Pelvic Pain Exchange Program 

- Friday 10th November - Pelvic Floor Muscle tone – Why It is Important and How to Change It: ICS Global Pelvic Pain Exchange Program 

- Sunday 19th November - ICS State of the Art at 39° CBU 

- 29th - 30th November - Incontinence: The Engineering Challenge XIV 

- Sunday 3rd December - Hip Causes of Pelvic Pain: ICS Global Pelvic Pain Exchange Program 

- 7th - 9th December - The 14th Annual Conference of the Libyan Urological Association (LUA) 

- 7th - 9th December - 8th Annual Meeting of the Society for Pelvic Research 

## ICS Membership 

The ICS recorded 2,760 members for 2023 (2022: 2,859). The Board increased the membership fee for 2023. The ICS strives to keep the membership fee as low as possible to keep the ICS accessible. The lower membership fees for nurses, physiotherapists and early career professionals were continued at the same rate. To extend the public benefit of ICS membership the Board continued to offer free one year membership for early career professionals that had not held ICS membership before. 

## ICS Committees 

ICS Committees continued to deliver education and research projects in a wide spectrum of areas. We thank the ICS Committee Chairs and Members for their incredible work. 

## **ICS Children and Young Adults Committee – Chair: Ashani Couchman** 

1. Completion of two position papers 

   - Position on intermittent catheterisation in adolescents 

   - Conservative management of faecal incontinence 

2. Successful application for a workshop at ICS 2023 

   - Accepted workshop on the holistic management of continence in the adolescence. We had a few challenges with presenters pulling out but we have a complete complement of speakers. 

3. Delivery of local educational meeting 

   - Serbian meeting delivered successfully with plans for another meeting in the future 

## **ICS Developing World Committee – Chair: Sherif Mourad** 

1. We organized a very successful fistula repair workshop in Mumbai – India on March 3-5, 2023. The event was heavily attended by around 400 attendees and was highly appreciated by the 

ICS Trustees Report 2023                                                                      7 



locals. We had participants from many countries included India, Bangladesh, Saudi Arabia, Kuwait, United Kingdom, Egypt and Argentina. 

2. We are currently preparing for the “Fistula Course” January 2024 and to continue of the successful history of this course. The course will “hopefully” take place in Lusaka – Zambia as we got a serious invitation to visit this area. 

3. The ICS Fistula Course became very popular among our membership and also among the International community interested in fistula and urinary incontinence in developing countries. The course attracts many trainees from different countries to join the 3-day training course which is a real hand on workshop. 

## **ICS Education Committee – Chair: Howard Goldman** 

1. Strengthened support for early career professionals. Increased number of observerships with funding. Session on mentorship at annual meeting. Mentoring round robin at annual meeting. 

2. Education area of website reviewed in depth. Older videos, those not current and those with few views (excepting certain areas with limited membership) have been archived. New podcasts added. Plans for capture of new videos from meeting reviewed. 

3. Plans for virtual “State of the Art” live webcasts finalized. Will have one on SUI, one on conservative management of incontinence and one on pelvic pain. Also, having one with Medtronic on SNM. 

## **ICS Ethics Committee – Chair: Anne Suskind** 

1. Dr. William Gibson is leading a 90-minute workshop titled “The Ethics of Continence Care in People Living with Dementia” at ICS 2023 in Toronto. This workshop was created and endorsed by the Ethics Committee and includes several Ethics Committee members including Dr. William Gibson, Dr. Anne Suskind (Ethics Committee Chair) and Joan Ostaszkiewicz. This workshop will serve to outline ethical challenges associated with caring for older adults with dementia and urinary incontinence in the context of the caregiver, aged care homes, and medical and surgical management. Dr. Gibson also recorded a podcast with Dr. Shannon Wallace to help advertise this workshop. This activity is aligned with the ICS Ethics Committee priority to bring educational content to the ICS Membership. 

2. Dr. Yahir Santiago-Lastra led the ICS Ethics Committee workshop in Vienna (ICS 2022) on “The Ethics of Sexuality and Pelvic Health”. This workshop got outstanding reviews from participants and Dr. Santiago-Lastra is now leading efforts to turn this workshop into an Ethics Committee sponsored publication. This activity is aligned with the ICS Ethics Committee priority to bring educational content to the ICS Membership. 

3. The Ethics Committee placed a call for the 2023 Ethics Committee Award. Unfortunately, submissions were reviewed and there were no submissions that were deemed to be deserving of the award. The committee will continue to work to publicize this award for ICS 2024. This activity is aligned with the mission to bring awareness to scholarship around ethical practices in the ICS community. 

4. The committee is working to update our mission statement and bylaws to reaffirm our commitment to our overseeing Ethical Standards for the ICS. 

## **ICS Neurourology Promotion Committee – Chair: Rizwan Hamid** 

1. Collaborative Lectures 

   - a. Joint workshop at the annual meeting of Urological Society of India, Feb 2023 

   - b. ICS NUPC lecture at the annual meeting of IUGA , Hague, Netherlands, June 2023 c. NUPC workshop at the annual ICS meeting in Sept 2023 

   - d. NUPC workshop at the Japanese Neurourology meeting in Sept 2023 (organised) 

2. Publications 

ICS Trustees Report 2023                                                                      8 



- a. _Continence_ : Lower urinary tract dysfunction in uncommon neurological diseases Part Report of the Neurourology Promotion Committee of International Continence Society Manuscript Number: Continence-D-23-00052 

- b. _Continence_ : Lower urinary tract dysfunction in uncommon neurological diseases Part Report of the Neurourology Promotion Committee of International Continence Society 

- c. _Continence_ : The International Continence Society (ICS) survey on intermittent catheterization and global practices with regard to the reuse of catheters 

## **ICS Nursing Committee – Chair: Tamara Dickinson** 

1. ICS Bowel diary published, March 2023 

2. Moved exciting nursing workshop content to the nursing forum. Topics are timely and should be of interest to all attendees of the meeting. Forum Keynote: The role of nursing in holistically sustainable continence care (T. Vaittinen). Followed by Bioethics, politics and fecal incontinence (A. Rajala), Updates on the Canadian Continence Nursing Front (F. Bates), Introduction of the ICS Bowel Diary (D. Bliss) 

3. Terminology for conservative interventions paper requested by the Standardisation Committee manuscript is in progress 

4. Podcasts in planning and committee member virtual attendance for committee meeting (only) in Madrid 

## **ICS Physiotherapy Committee – Chair: Paula Igualada-Martinez** 

1. For the first time since 2019, the Physiotherapy Committee successfully submitted a Workshop proposal. 

2. We have developed a Masterclass on Conservative Management of UI scheduled for the first quarter of 2024. The finalised content and list of speakers will be evaluated during our committee meeting, after which it will be submitted to both the Education Committee and the BOT. 

3. We have examined the content of an article for the Continence Journal concerning Level 1 Physiotherapeutic assessment of female urinary incontinence, now inclusive of males. This will also undergo a review in Toronto before forwarding it to the BOT. 

4. The Physiotherapy Forum has an incredible line up of international physiotherapists. Notably, attendance numbers have doubled compared to last year, and have seen an uptick since our last in-person conference held in Sweden. 

## **ICS Scientific Committee - Chair: Adrian Wagg** 

State of the Art Lectures 

- SOA 1 The Approach and Treatment of Sexual Dysfunction in Men **Gerald Brock** 

- SOA 2 Overactive Bladder Drugs and Dementia - Where Does the Truth Lie? **Howard Goldman** 

- • SOA 3 Bladder Pain Syndromes: Have we made any advances in our understanding? **Michael Chancellor** 

## State of the Art Round Tables 

- RT1 Pelvic Pain: from Syndromes to Treatable Diagnostic Entities 

- RT2 Women’s Sexual Health and Pelvic Floor Dysfunction 

- RT3 Nocturia - A Circadian Dysrhythmia 

- RT4 Emerging Neuromodulation Technologies for the Treatment of OAB 

- • RT5 Optimal service delivery for conservative therapies 

- RT6 What's the role of energy based devices in pelvic floor dysfunction? 

ICS Trustees Report 2023                                                                      9 



- RT7 Unravelling OAB: the road to precision treatments 

- RT8 What do we really know about the external urethral sphincter? 

- The statistics for this year’s meeting are attached. 

## **ICS Standardisation Steering Committee - Chair: Matthias Oelke** 

## 1. Publications: 

- i. Kocjancic E, Chung E, Alvarez Garzon J, Haylen H, Iacovelli V, Jaunarena J, Locke J, Millman A, Nahon I, Ohlander S, Pang R, Plata M, Acar O. International Continence Society (ICS) report on the terminology for sexual health in men with lower urinary tract (LUT) and pelvic floor (PF) dysfunction. _Neurourol. Urodyn_ . 2022; 41: 140 – 165. 

- ii. Doumouchtsis SK, De Tayrac R, Lee J, Daly O, Melendez-Munoz J, M Lindo FM, Cross A, White A, Cichowski S, Falconi G, Haylen B. An International Continence Society (ICS)/International Urogyncological Association (IUGA) joint report on the terminology of the assessment and management of Obstetric Pelvic Floor Disorders. _Int Urogynecol J._ 2023; 34(1): 1-42. 

- iii. Bliss DZ, Igualada-Martinez P, Engberg S, Herbert JH, Gurvich OV, Igbedioh C, Hunter A, Voelkl J, Cuiñas León K, Schizas AMP. Standard Questions for a bowel diary to assess fecal incontinence in adults: A consensus project of the International Continence Society. _Continence_ . 2023; 6: 100588. 

- iv. Sihra R, Barratt R, Hamid R, Kessler TM, Sievert KD, Neshatian L, Paquette I, Sahai A, Thomas L, Thakare N, Sontoro GA, Higazy A, Fahmy M, Zarate-Lopez N, Heldwein FL, Williams A, Emmanuel A, Drake MJ. The implications of neurogenic bowel dysfunction for urinary tract reconstruction in neurogenic urinary tract dysfunction: An International Continence Society working group report. _Continence_ . 2023; 6: 100590. 

- v. Sinha S, Hamid R, Chartier-Kastler EJ,Del Popolo G, Denys P, Haslam C, Panicker JN, Sloane K, Vasudeva P, Vrijens DMJ, Braschi E. The International Continence Society (ICS) survey on intermittent catheterization and global practices with regard to the reuse of catheters. _Continence._ 2023; 6: 100597. 

- vi. Rosier PFWM, Valdevenito JP, Smith P, Sinha S, Speich J, Gammie A; Members of the ICS Working Group PFS23. ICS-SUFU standard: Theory, terms, and recommendations for pressureflow studies performance, analysis, and reporting. Part 1: Background theory and practice. _Neurourol Urodyn_ . 2023 Apr 25. Online ahead of print. 

- vii. Rosier PFWM, Gammie A, Valdevenito JP, Speich J, Smith P, Sinha S; members of the ICS Working Group PFS23. ICS-SUFU standard: Theory, terms, and recommendations for pressureflow studies performance, analysis, and reporting. Part 2: Analysis of PFS, reporting, and diagnosis. _Neurourol Urodyn_ . 2023 May 4. Online ahead of print. 

## 2. Translations: 

- i. ANLUD Report from English to _French_ (with / for E. Chartier-Kastler) 

- ii. ANLUD Report from English to _Spanish_ (with / for C. Alvear) 

- iii. ANLUD Report from English to _Portuguese_ (with / for C. Alvear) 

## **ICS Urodynamics Committee – Chair: Tufan Tarcan** 

1. TEACHING MODULES: Many teaching modules were initiated or re-organized last year. A) Best practice for Videourodynamics: A teaching module of the International Continence Society Urodynamics Committee. The module led by Alex Digesu was re-initiated and re-organized in terms of co-authors. The paper was finalized and submitted to the ICS official journal for publication in June 2023 with the Manuscript Number: Continence-D-23-00038. 

ICS Trustees Report 2023                                                                      10 



2. URODYNAMIC CHARTS REVIEW PROJECT: This project of the Urodynamics Committee was pioneered by Andrew Gammie aiming to increase the quality of UD studies worldwide to the ICS standards. 

3. ASSESSMENT OF SENSATION DURING UDS: The project led by Elise De and the urodynamic committee is finalised. The manuscript is under preparation. 

## **Critical Success Factors (CSF’s) / Key Performance Indicators (KPI’s)** 

CSFs identified at last strategic review concluded in 2022. New KPI measurements for 2023 report. 

## **1. CSF Establish financial security: protect, diversify and increase income** 

- Create Industry Committee 

- Maximise income from ICS membership: secure, affiliates, new markets 

- Create a risk register and review regularly 

- Investigate options for fundraising: foundations, crowdfunding, grants 

Outcome: most objectives met or partially met/in process 

**KPI** Reserve Policy Met: 

|**2023**|**£ GBP**|**% of target**|
|---|---|---|
|Actual|**834,266**|76.7|
|Target|1,087,354||



Below target. As detailed above, main cause was the much lower income from our annual meeting post covid. Also a slight drop in membership. 

Action for 2024: Control costs, create new funding streams not dependent on annual meeting 

## **2. CSF Ensure the highest quality scholarly activity** 

- Establish and grow the ICS Journals 

- Ensure a constant stream of high quality ICS publications 

- Board to work with Scientific and Education Committees on a project plan for the annual meeting programme 

- Develop further e-learning opportunities for ICS members and meeting delegates 

Outcome: All objectives met / in progress. 

**KPI** – propose to measure Impact Factor of new ICS Journals – these figures will be published once Journal has been accepted by PubMed (this is expected to take 2 years). KPI target to compare impact factor with previous official society journal’s impact factor. 

## **3. Improve Governance (Board/organisational)** 

- Establish Governance and Nominations Committee 

- Update Articles and Bylaws in line with report recommendations 

- Implementing the actions from the governance review 

- Broadening the range of skills and experience on the Board 

- 4 meetings a year of the Board: two times virtual, two times live 

- Improve efficiency of Board meetings: agenda items and papers 

Outcome: All objectives met. 

ICS Trustees Report 2023                                                                      11 




## **Strengthen the organisation (staff and committees)** 

- Review organisation structure and resourcing, including staffing 

- Review all activity and rationalise based on ICS strategy 

- Decide which committees and activities should continue/cease 

- Put in place measures and reviews to ensure progress and high standards 

Outcome: All objectives met. 

KPI – Employee Performance Targets 

**Performance % of Staff Targets Met Target** 5 25 25 100.0 ~~|||~~ 

Additional new KPI for 2024 – measure Committee achievements vs 2023 targets 

**Put in place programme to reach out the potential new members outside the US and Europe** 

- Create a plan and timeline for how to reach 50% ICS members 

- Define most important countries to ICS outside US/Europe 

- Partnerships … 

- Translations … 

Outcome: objectives met, new 5 year membership growth strategy developed. 

## **KPI** – Membership Growth 

|– Membership Growthp Growth<br>**Year**<br>**Membership**<br>**Growth**<br>**%**<br>2023<br>2,760<br>-3.5<br>2022<br>2,859<br>~~=~~|– Membership Growthp Growth<br>**Year**<br>**Membership**<br>**Growth**<br>**%**<br>2023<br>2,760<br>-3.5<br>2022<br>2,859<br>~~=~~|
|---|---|
|Unfortunately membership reduced in 2023. Action – 5 year growth strategy - focus on benefits of|Unfortunately membership reduced in 2023. Action – 5 year growth strategy - focus on benefits of|
|membership, develop new partnerships, identify needs in target regions.||



## **Investments Performance** 

The charity’s investment portfolio is diverse and set in accordance with the agreed risk and ethical policy of the Board. The valuation of the portfolio rose by 0.69% in 2023, a profit of £5,186, which has been declared in the accounts as net gains on investments (2022: loss of £30,399). 

£2,352 was received in interest from bank accounts and has been declared as income from investments for the year to 31 December 2023 (2022: £381). 

ICS Trustees Report 2023                                                                      12 



## **Financial Review** 

## **Results for the year** 

The consolidated results of the charity and its trading subsidiary, Conticom, showed net outgoing funds in the year of £110,462 (2022: net outgoing funds of £235,807) with closing consolidated funds of £834,266 (2022: £944,728). 

## **Consolidated Income** 

Income in the year was from the Annual Meeting and trading of £220,772 (2022: £567,119), membership fees £215,654 (2022: £209,327), royalty income totalling £1,153 (2022: £2,562), donations and legacies of £93,263 (2022: £31,565), Educational activities totalling £609 (2022: £4,564) and interest from Investments of £2,352 (2022: £381) 

With this funding the Charity has been able to finance: the staffing and technical costs of hosting the annual meeting, educational activities, including awards, observerships, courses and lectures, the running costs of the ICS Office that continues to support the Board, committees, the membership of 2760 and support for the ICS journals. The majority of award costs were covered by an educational grant received from Pfizer. 

The total profit of the trading subsidiary was £70,860 (2022: loss of £22,464). 

## **Consolidated Expenditure** 

Expenditure in the year was on Educational Activities £258,612 (2022: £263,513), Annual Meeting expenditure £104,721 (2022: £447,556) and Publication and Membership £286,118 (2022: £309,857). 

The variation in consolidated income and expenditure for 2022 compared to 2023 is due to the requirement for ICS to record a significant proportion of meeting registration income and costs in its accounts in 2022 in order to qualify for the Austrian VAT reduction. 

## **Annual Meeting** 

The Annual Meeting is an annual international medical and scientific conference for specialists in the medical and scientific disciplines relevant to the charitable objects of ICS. Organisation of the Annual Meeting is contracted to an organiser (this has been Kenes International since 2008 and will, under their current contract, continue in the role until 25 October 2024), by Conticom-ICS Limited (the wholly-owned trading subsidiary of ICS). 

The terms of the relevant agreement (on which legal advice was taken) provide for the organiser to accept all financial risks and for a proportion of any net surplus to be passed to ICS. 

In order to mitigate risk the Trustees implemented a policy of rotating annual meeting locations. This reduces the risk to the ICS of locations that may be less likely to generate a surplus. The updated four year rotation policy involves a European meeting every other year, with the alternate years in a destination outside of Europe; on the provision that an adequate surplus is forecast. The society continues to be reliant on income from the annual meeting, so ensuring a financially successful meeting is important. The ICS will continue to reach a range of countries through its educational course programme. 

## **Industry Supported Projects Outside of the Annual Meeting** 

As income from the annual meeting has been highly variable and lower since the pandemic, the society has been developing other educational project proposals outside of the annual meeting. The intention 

ICS Trustees Report 2023                                                                      13 



is to develop alternative sources of income outside of the annual meeting directly supported by our industry partners. Multiple project concepts were developed in 2023 and proposed to our industry partners for educational support grants/contracts with a view to delivering them in 2024-2026. 

As requested by the membership, the table below shows an overview of the Annual Meeting income, expenditure and surplus. 

||**£**<br>~~a~~|**£**<br>~~a~~|**£**<br>~~a~~|**£**<br>~~a~~|**£**<br>~~a~~|
|---|---|---|---|---|---|
|~~a~~|**2023**|**2022**|**2021**|**2020**|**2019**|
|**Sponsorship &**<br>**exhibition**<br>~~pt~~|255,478<br>~~pt~~|448,618<br>~~pt~~|324,141<br>~~pt~~|312,172<br>~~pt~~|486,948<br>~~pt~~|
|**Registrations**<br>~~a~~|456,997<br>~~a~~|464,622<br>~~a~~|183,695<br>~~a~~|118,088<br>~~a~~|774,086<br>~~a~~|
|**Other income**<br>~~a~~|122,262<br>~~a~~|86,521<br>~~a~~|15,589<br>~~a~~|673<br>~~a~~|116,298<br>~~a~~|
|**Total income**<br>~~a~~|834,737<br>~~a~~|999,761<br>~~a~~|523,425<br>~~a~~|430,933<br>~~a~~|1,377,332<br>~~a~~|
|**Total expenditure**<br>~~a~~|905,735<br>~~a~~|971,650<br>~~a~~|391,073<br>~~a~~|401,367<br>~~a~~|1,114,308<br>~~a~~|
|**Surplus/(Deficit)**<br>~~pot~~|(70,998)<br>~~potty~~|28,111<br>~~ty~~|132,352<br>~~ty~~|29,566|263,024|
|**Surplus of which**<br>**Conticom received**<br>**including Scientific**<br>**Services Fee**<br>~~pot~~|129,600<br>~~potty~~|173,061<br>~~ty~~|298,592<br>~~ty~~|218,009|395,734|



## **Reserves Policy** 

In order to maintain prudent levels of financial reserves the following conditions should be met: 

- a) Provide a safeguard of two years’ estimated future operating costs of ICS and Conticom ICS Limited, (as ICS operates on an annual cycle and its key annual event, the Annual Meeting, has to be pre-planned on a four year cycle). 

   - Calculations are to be based on estimated future combined operating costs for the next two years. 

   - These operating costs are to only take into account running costs not guaranteed to be financed by matching income. 

- b) Provide an element of contingency for unforeseen liabilities. 

   - Which should be £100,000 

- c) Provide a permanent base for the Charity and safeguard future projects. 

ICS Trustees Report 2023                                                                      14 



The estimated operating costs of ICS and Conticom ICS Limited are £496,903 for 2024 and £490,451 for 2025, giving a total of £987,354 for both years. This does not include budgeted expenditure for educational courses, grants, fellowships and awards as these are non-essential expenditure. 

## **This gives a desired level of reserves of £1,087,354 as at 31.12.2023.** 

As of 31st December 2023, the consolidated balance sheet showed the Charity and its subsidiary had combined carried forward funds of **£834,266** (2022: £944,728); therefore below the level of reserves required by £253,088.  The trading subsidiary continued to support the Charity in meeting its objectives. 

The trustees acknowledge for 2023 the Charity will be under its reserve policy, which in part is due to the legacy of the COVID years. The Board has brought in measures to increase current income and provide new income. The current reserves policy will be reviewed by the Board and amended if this is the agreement. In the interim all costs will be restrained. Costs and activities of the ICS will be reviewed steadily in line with ICS strategy and objectives. 

## **Plans for Future Periods** 

## ICS Annual Meeting 2024 

Honorary Meeting Chairs: Pedro Hernandez, Carmen Gonzalez Enguita Local Scientific Programme Chair: Alicia Martín Martínez 

The 54[th] Annual Meeting of the ICS will take place at the IFEMA in Madrid, Spain. 

## Future Meetings 

ICS-EUS 2025: Abu Dhabi. Meeting Chairs: AbdulQadir Al-Zarooni, Sherif Mourad ICS 2026: Maastricht, Netherlands. Honorary Meeting Chair: Gommert Van Koeveringe ICS 2027: Florence, Italy. Honorary Meeting Chair: Enrico Finazzi Agro 

## **ICS Strategic Plan** 

The Board will review and update the ICS strategic goals in order to direct ICS resources to the most important areas of work for the financial sustainability of the charity, and in order to achieve societal goals for the charity’s mission to deliver public benefit. 

## **Industry Supported Education Projects** 

To address the variable financial surplus generated by the annual meeting, the Board of Trustees plan to develop new additional sources of funding from industry supported educational projects in 2024. 

## **ICS Journals** 

The Board will expand on actions to establish and grow the ICS journals. An application will be submitted for PubMed accreditation of the journals. An important milestone for the journals. 

## **ICS Committees** 

ICS Committees continue to develop plans for addressing the needs of our members and the public. A new “top 3” priority system has been introduced to focus activities of each committee. As volunteers we owe a huge debt to all committee members for their outstanding dedication to the field of 

ICS Trustees Report 2023                                                                      15 



continence to further our understanding of the bladder and pelvic floor and highlight and alleviate the suffering of patients worldwide. 

## **ICS Children and Young Adults Committee – Chair: Ashani Couchman** 

1. Ongoing podcasts - Two further planned podcasts – once every three months 

2. Deliver 2 workshops 

   - a. International collaboration for delivery of a position statement on bowel care management 

   - b. Deliver a workshop focussed on the paeds and adolescent factors effecting urodynamic practice 

3. Increase visibility of the community 

   - a. Two committee meetings to be organised – just assistance with zoom and two doodle polls for timing 

## **ICS Developing World Committee – Chair: Sherif Mourad** 

1. Holding a workshop during ICS 2024 in Madrid. 

2. Holding the ICS Fistula Course 2024 in Lusaka - Zambia. 

3. Having ICS speakers in the national meeting of developing countries. 

4. Collaborate with centers in these countries as online events to try to set up online seminars/webinars. Possible issues to deal with are; Fistula (prevention, diagnosis, surgical management), Native tissue repair of POP, Female urinary incontinence, Male LUTS, Neurogenic Bladder Dysfunction and Conservative Management of Urinary Incontinence. 

5. Publishing new papers about urogynecological disorders in the developing world. 

## **ICS Education Committee – Chair: Howard Goldman** 

1. Standing bimonthly interactive webinar for ICS members. Improve “advertising” of all of our great educational videos, etc – greater social media presence 

2. Manage observerships/grants/early career group 

3. Increase colorectal and nursing exposure 

## **ICS Ethics Committee – Chair: Anne Suskind** 

1. ICS Ethics Workshop at ICS 2024 Madrid 

2. ICS Ethics Award 2024 

3. ICS Ethics Committee Paper on “The Ethics of Sexuality and Pelvic Health” 

## **ICS Neurourology Promotion Committee – Chair: Rizwan Hamid** 

1. Request ICS Board to approve award a certificate and facilitate a 2 week visiting fellowship at the following annual conference with the NU teaching unit for the best presentation in neurourology at the ICS Annual meeting to a young neuro-urologist 

2. Committee members to facilitate holding collaborative workshops with international societies in respective countries 

3. Committee members to deliberate on 2 research questions for publications in the upcoming year 

## **ICS Nursing Committee – Chair: Tamara Dickinson** 

1. Submission of high quality nursing workshop and forum for Madrid 2024 

2. Quality publications currently in process 

   - a. Terminology for conservative interventions 

   - b. Food and Fluid Interventions 

3. Nursing focused series of 3 podcasts 

ICS Trustees Report 2023                                                                      16 



## **ICS Physiotherapy Committee – Chair: Paula Igualada-Martinez** 

1. Online Masterclass of Conservative Management of UI: taking the ICI guidelines into clinical practice 

2. Publication of Level 1 Physiotherapeutic assessment of female and male urinary incontinence in the Continence Journal. 

3. There are various proposals on the agenda for discussion at the Physiotherapy meeting in Toronto, following which the Chair will present them at the BOT meeting. 

## **ICS Scientific Committee - Chair: Adrian Wagg** 

Create the Scientific Programme for ICS 2023 Toronto: 

1. Develop State of the Art programme of lectures & roundtables 

2. Call for research abstract submissions and review abstracts anonymously 

3. Select the best research for presentation in podium sessions and eposters 

4. Publish all accepted abstracts online and publish podium abstracts in _Continence_ 

## **ICS Standardisation Steering Committee - Chair: Matthias Oelke** 

1. Finalization of ongoing terminology reports 

2. Identification of terminology reports which are outdated and need to be updated in the near future 

3. Translation of important terminology reports and the entire glossary from English to French, Italian, Portuguese, Spanish and Turkish 

## **ICS Urodynamics Committee – Chair: Tufan Tarcan** 

1. ICS Urodynamics E-learning project: 

2. ICS teaching modules 

3. Urodynamic Charts Review Project 

## **Approved by the Trustees and signed on their behalf by:** 

## **Steven Schraffordt Koops Treasurer** 

**Date 24/09/2024** 

ICS Trustees Report 2023                                                                      17 



## **INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF THE INTERNATIONAL CONTINENCE SOCIETY** 

I report to the charity trustees on my examination of the accounts of company for the year ended 31 December 2023. 

## **Responsibilities and basis of report** 

As the charity trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’). 

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your company’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act. 

## **Independent examiner’s statement** 

Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the Act. I confirm that I am qualified to undertake the examination because I am a member of ICAEW, which is one of the listed bodies. 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

1. accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

Matthew Bracher BSc FCA Institute of Chartered Accountants in England and Wales For and on behalf of Haines Watts (Western) Limited Bath House 6-8 Bath Street Bristol BS1 6HL 

Date: 24/09/2024 

Page | 18 



## **THE INTERNATIONAL CONTINENCE SOCIETY STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME & EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2023** 

|Notes<br>**Income from:**<br>Donations and legacies<br>2<br>Investments<br>_Charitable activities:_<br>Annual meeting<br>Distribution from trading<br>subsidiary<br>3<br>5<br>Subscription and royalties<br>Educational activities<br>4<br>6<br>Total income<br>**Expenditure on:**<br>_Charitable activities:_<br>Educational activities<br>7<br>Publication and membership<br>Annual meeting<br>7<br>7<br>Total expenditure<br>Net gain/(losses) on investments<br>14<br>**Net income/(expenditure) and**<br>**movement in funds**<br>**Reconciliation of funds:**<br>Fund balances brought forward<br>Fund balances carried forward|**Unrestricted**<br>**Restricted**<br>**Year**<br>**Year**<br>**ended**<br>**ended**<br>**31.12.23**<br>**31.12.23**<br>**£**<br>**£**<br>**73,742**<br>**19,521**<br>**2,327**<br>**-**<br>**45,217**<br>**-**<br>**-**<br>**-**<br>**216,807**<br>**609**<br>**-**<br>**-**|**Total**<br>**Year**<br>**ended**<br>**31.12.23**<br>**£**<br>**93,263**<br>**2,327**<br>**-**<br>**45,217**<br>**216,807**<br>**609**|Unrestricted<br>Restricted<br>Total<br>Year<br>Year<br>Year<br>ended<br>ended<br>ended<br>31.12.22<br>31.12.22<br>31.12.22<br>£<br>£<br>£<br>15,352<br>16,213<br>31,565<br>381<br>512,128<br>-<br>-<br>-<br>-<br>381<br>512,128<br>-<br>211,889<br>4,564<br>-<br>-<br>211,889<br>4,564|
|---|---|---|---|
||**338,702**<br>**19,521**<br>**222,369**<br>**36,243**<br>**286,118**<br>**-**<br>**-**<br>**-**|**358,223**<br>**258,612**<br>**286,118**<br>**-**|744,314<br>16,213<br>760,527<br>255,349<br>8,164<br>263,513<br>309,857<br>370,101<br>-<br>-<br>309,857<br>370,101|
||**508,487**<br>**36,243**|**544,730**|935,307<br>8,164<br>943,471|
||**5,186**<br>**-**|**5,186**|(30,399)<br>-<br>(30,399)|
||**(164,599)**<br>**(16,722)**<br>**962,024**<br>**17,222**|**(181,321)**<br>**979,246**|(221,392)<br>8,049<br>(213,343)<br>1,183,416<br>9,173<br>1,192,589|
||**797,425**<br>**500**|**797,925**|962,024<br>17,222<br>979,246|



Page | 19 



## **THE INTERNATIONAL CONTINENCE SOCIETY CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING CONSOLIDATED INCOME & EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2023** 

|Notes<br>**Income from:**<br>Donations and legacies<br>Investments<br>Charitable activities:<br>Annual meeting and trading<br>2<br>3<br>5<br>Subscription and royalties<br>Educational activities<br>4<br>6<br>Total income<br>**Expenditure on:**<br>_Charitable activities:_<br>Educational activities<br>7<br>Publication and membership<br>7<br>Annual meeting<br>7<br>Total expenditure<br>Net gains/(losses) on investments<br>14<br>**Net income/(expenditure) and**<br>**movement in funds**<br>**Reconciliation of funds:**<br>Fund balances brought forward<br>Fund balances carried forward|**Unrestricted**<br>**Restricted**<br>**Total**<br>Unrestricted<br>Restricted<br>Total<br>**Year**<br>**Year**<br>**Year**<br>Year<br>Year<br>Year<br>**ended**<br>**ended**<br>**ended**<br>ended<br>ended<br>ended<br>**31.12.23**<br>**31.12.23**<br>**31.12.23**<br>31.12.22<br>31.12.22<br>31.12.22<br>**£**<br>**£**<br>**£**<br>£<br>£<br>£<br>**73,742**<br>**2,352**<br>**220,772**<br>**19,521**<br>**-**<br>**-**<br>**93,263**<br>**2,352**<br>**220,772**<br>15,352<br>381<br>567,119<br>16,213<br>-<br>-<br>31,565<br>381<br>567,119<br>**216,807**<br>**609**<br>**-**<br>**-**<br>**216,807**<br>**609**<br>211,889<br>4,564<br>-<br>-<br>211,889<br>4,564<br>**514,282**<br>**19,521**<br>**533,803**<br>799,305<br>16,213<br>815,518<br>**222,369**<br>**36,243**<br>**258,612**<br>255,349<br>8,164<br>263,513<br>**286,118**<br>**-**<br>**286,118**<br>309,857<br>-<br>309,857<br>**104,721**<br>**-**<br>**104,721**<br>447,556<br>-<br>447,556<br>**613,208**<br>**36,243**<br>**649,451**<br>1,012,762<br>8,164<br>1,020,926<br>**5,186**<br>**-**<br>**5,186**<br>(30,399)<br>-<br>(30,399)<br>**(93,740)**<br>**(16,722)**<br>**(110,462)**<br>(243,856)<br>8,049<br>(235,807)<br>**927,506**<br>**17,222**<br>**944,728**<br>1,171,362<br>9,173<br>1,180,535<br>**833,766**<br>**500**<br>**834,266**<br>927,506<br>17,222<br>944,728|
|---|---|
||**514,282**<br>**19,521**<br>**533,803**<br>799,305<br>**222,369**<br>**36,243**<br>**258,612**<br>255,349<br>**286,118**<br>**-**<br>**286,118**<br>309,857<br>**104,721**<br>**-**<br>**104,721**<br>447,556|
||**613,208**<br>**36,243**<br>**649,451**<br>1,012,762<br>**5,186**<br>**-**<br>**5,186**<br>(30,399)|
||**(93,740)**<br>**(16,722)**<br>**(110,462)**<br>(243,856)<br>**927,506**<br>**17,222**<br>**944,728**<br>1,171,362|
||**833,766**<br>**500**<br>**834,266**<br>927,506|



The statement of financial activities includes all gains and losses recognised in the year. 

All income and expenditure derives from continuing activities. 

Page | 20 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **BALANCE SHEET AS AT 31 DECEMBER 2023** 

|Notes<br>**FIXED ASSETS:**<br>Intangible assets<br>12<br>Investments<br>14<br>**CURRENT ASSETS:**<br>Debtors<br>15<br>Cash at bank and in hand<br>**CREDITORS:**Amounts falling<br>due within one year<br>16<br>**NET CURRENT ASSETS:**<br>**TOTAL ASSETS LESS CURRENT**<br>**LIABILITIES:**<br>**FUNDS:**<br>Unrestricted funds<br>18<br>Restricted funds<br>18||**2023**|**2023**|**£**<br>**1,244**<br>**759,200**<br>**760,444**<br>**37,481**<br>**797,925**<br>**797,425**<br>**500**<br>**797,925**|2022|||
|---|---|---|---|---|---|---|---|
|||**£**<br>**8,630**<br>**123,759**<br>**132,389**<br>**(94,908)**|||£<br>99,335<br>174,143<br>273,478<br>(49,645)||£<br>1,399<br>754,014<br>755,413<br>223,833|
||||||||979,246|
||||||||962,024<br>17,222|
||||||||979,246|



The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023. 

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006. 

The trustees acknowledge their responsibilities for 

- (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and 

- (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. 

These financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to charitable small companies. 

The financial statements were approved by the Trustees on 24/09/2024 and were signed on their behalf by: 

Dr S Schraffordt Koops - TREASURER 

**Company Registration No. 03589542** 

Page | 21 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

**CONSOLIDATED BALANCE SHEET AS AT 31 DECEMBER 2023** 

|Notes<br>**FIXED ASSETS:**<br>Intangible assets<br>12<br>Tangible assets<br>13<br>Investments<br>14<br>**CURRENT ASSETS:**<br>Debtors<br>15<br>Cash at bank and in hand<br>**CREDITORS:**Amounts falling<br>due within one year<br>16<br>**NET CURRENT ASSETS:**<br>**TOTAL ASSETS LESS CURRENT**<br>**LIABILITIES:**<br>**FUNDS:**<br>Unrestricted funds<br>19<br>Restricted funds<br>19|**2023**<br>**£**<br>**£**<br>**1,244**<br>**4,378**<br>**759,199**<br>**764,821**<br>**22,610**<br>**141,193**<br>**163,803**<br>**(94,358)**<br>**69,445**<br>**834,266**<br>**833,766**<br>**500**<br>**834,266**||2022||
|---|---|---|---|---|
||**£**<br>**22,610**<br>**141,193**<br>**163,803**<br>**(94,358)**||£<br>37,885<br>221,898<br>259,783<br>(76,045)|£<br>1,399<br>5,578<br>754,013|
|||||760,990<br>183,738|
|||||944,728|
|||||927,506<br>17,222|
|||||944,728|



The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023. 

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006. 

The trustees acknowledge their responsibilities for 

- (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and 

- (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. 

These financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to charitable small companies. 

The financial statements were approved by the Trustees on 24/09/2024 and were signed on their behalf by: 

Dr S Schraffordt Koops - TREASURER 

**Company Registration No. 03589542** 

Page | 22 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **STATEMENT OF CASH FLOWS AND CONSOLIDATED STATEMENT OF CASH FLOWS FOR YEAR ENDING 31 DECEMBER 2023** 

|Notes<br>**Cash flows from operating activities:**<br>Net cash provided by (used in) operating activities<br>1<br>**Cash flows from investing activities:**<br>Interest income<br>Purchase of property, plant and equipment<br>**Net cash provided by (used in) investing activities**<br>**Change in cash and cash equivalents in the**<br>**reporting period**<br>2<br>**Cash and cash equivalents at the beginning of the**<br>**reporting period**<br>**Cash and cash equivalents at the end of the**<br>**reporting period**|**Charity**<br>**2023**<br>**£**<br>Charity<br>2022<br>£<br>**Group**<br>**2023**<br>**£**<br>Group<br>2022<br>£<br>**(52,711)**<br>(122,121)<br>**(81,433)**<br>(86,467)<br>**2,327**<br>381<br>**2,352**<br>381<br>**-**<br>-<br>**(1,624)**<br>(5,681)|
|---|---|
||**2,327**<br>381<br>**728**<br>(5,300)|
||**(50,384)**<br>(121,740)<br>**(80,705)**<br>(91,767)|
||**174,143**<br>295,883<br>**221,898**<br>313,665|
||**123,759**<br>174,143<br>**141,193**<br>221,898|



## **NOTES TO CASH FLOWS:** 

## **1. RECONCILIATION OF NET MOVEMENT IN FUNDS TO NET CASH FLOW FROM OPERATING ACTIVITIES** 

||**Charity**|Charity|**Group**|Group|
|---|---|---|---|---|
||**2023**|2022|**2023**|2022|
||**£**|£|**£**|£|
|Net movement in funds|(**181,322)**|(213,343)|**(110,463)**|(235,807)|
|Add back depreciation/amortisation charge|**155**|155|**2,980**|4,209|
|Deduct interest income shown in investing activities|**(2,327)**|(381)|**(2,352)**|(381)|
|Deduct/add net (gain)/loss on investments|**(5,186)**|30,399|**(5,186)**|30,399|
|Decrease (increase) in debtors|**90,705**|106,001|**78,795**|170,437|
|Increase (decrease) in creditors|**45,264**|(44,952)|**(45,207)**|(55,324)|
||–––––––|–––––––|––––––|–––––––|
|**Net cash (used)/gained in/from operating activities**|**(52,711)**|(122,121)|**(81,433)**|(86,467)|



Page | 23 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **STATEMENT OF CASH FLOWS AND CONSOLIDATED STATEMENT OF CASH FLOWS FOR YEAR ENDING 31 DECEMBER 2023** 

## **NOTES TO CASH FLOWS – continued:** 

## **2. ANALYSIS OF CHANGES IN NET FUNDS - CHARITY** 

|**At** **1.1.23**<br>**Cash flow**<br>**At**<br>**£**<br>**£**<br>**Net cash**<br>Cash at bank and in hand<br>**174,143**<br>**(50,384)**<br>174,143<br>**(50,384)**<br>**ANALYSIS OF CHANGES IN NET FUNDS - GROUP**<br>**At 1.1.23**<br>**Cash flow**<br>**At**<br>£<br>£<br>**Net cash**<br>Cash at bank and in hand<br>**221,898**<br>**(80,705)**<br>**221,898**<br>**(80,705)**|**31.12.23**<br>**£**<br>**123,759**|
|---|---|
||**123,759**|
||**31.12.23**<br>**£**<br>**141,193**|
||**141,193**|



Page | 24 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS** 

## **FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 1. **ACCOUNTING POLICIES** 

## **Basis of preparing the financial statements** 

The International Continence Society is a company limited by guarantee, registered in England and Wales.  In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity. 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) issued in October 2019, the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), the Companies Act 2006 and UK Generally Accepted Accounting Practice. 

The financial statements are prepared on a going concern basis under the historical cost convention, modified to include certain items at fair value. The financial statements are presented in sterling which is the functional currency of the charity and rounded to the nearest £. 

The trustees consider that there are no material uncertainties about the charity’s ability to continue as a going concern. 

The charity constitutes a public benefit entity as defined by FRS 102. The address of the registered office and place of business is given in the charity information on page 1 of these financial statements.  The nature of the charity’s operations is a membership society for professionals working in the field of incontinence. 

The principal accounting policies adopted by the charity in drawing up its financial statements are as follows: 

## **(a) Income** 

All incoming resources are including in the Statement of Financial Activities when the charity is legally entitled to the income after any performance conditions have been met, the amount can be measured reliably and it is probable that income will be received. Incoming resources from subscriptions are recognised in the Statement of Financial Activities on a calendar year basis and are deferred where they are received in advance. 

For donations to be recognised, the charity will have been notified of the amounts and the settlement date in writing. If there are conditions attached to the donation and this requires a level of performance before entitlement can be obtained, then income is deferred until those conditions are fully met or the fulfilment of those conditions is within the control of the charity and it is probable that they will be fulfilled. 

## **(b) Group Accounts** 

The results of Conticom-ICS Limited, a wholly owned subsidiary, have been consolidated on a line by line basis in the Statement of Financial Activities, the Balance Sheet and The Statement of Cashflows. 

## **(c) Fund Accounting** 

General funds are unrestricted funds which are available for use at the discretion of the trustees in furtherance of general objectives of the charity and which have not been designated for other purposes. 

Restricted funds are funds donated for use in a particular area or for specific purposes, the use of which is restricted to that area of purpose. 

Page | 25 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 1. **ACCOUNTING POLICIES - continued** 

## **(d) Investment assets** 

The investment in the subsidiary is stated at cost. Listed investments held for the continuing benefit of the charity and are treated as fixed assets and are valued at fair value at the balance sheet date. 

## **(e) Expenditure** 

All expenditure included in the Statement of Financial Activities is accounted for on an accruals basis. 

Charitable activities include expenditure associated with educational activities, together with publication and membership, and include both the direct costs and support and governance costs relating to these activities. 

Support and governance costs are those functions the assist the work of the charity but do not directly undertake charitable activities. These costs have been allocated to expenditure on charitable activities as set out in note 7. 

Any irrecoverable VAT is charged to the Statement of Financial Activities or capitalised as part of the asset cost, where appropriate. 

## **(f) Intangible Assets** 

The domain name is stated at cost less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended. 

The domain name is being amortised evenly over 20 years. 

## **(g) Tangible Fixed Assets** 

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses.  Cost includes costs directly attributable to making the asset capable of operating as intended. 

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life: 

Fixtures and fittings -25% on cost Computer equipment -33% on reducing balance 

## **(h) Foreign Currencies** 

Transactions in foreign currencies are recorded at the rate ruling at the date of transaction. Monetary assets and liabilities are retranslated at the rate of exchange ruling at the balance sheet date. All differences are taken to the Statement of Financial Activities. 

## **(i) Hire purchase and leasing commitments** 

Rentals paid under operating leases are charged to the Statement of Financial Activities over the period to which they relate. 

## **(j) Pension costs** 

The charity operates a defined pension contribution scheme. Contributions payable for the year are charged in the Statement of Financial Activities. The liability and expense is allocated between activities and between restricted and unrestricted funds on a time apportioned basis. 

Page |26 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 1. **ACCOUNTING POLICIES - continued** 

## **(l) Financial Instruments** 

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised when the charity becomes party to the contractual provisions of the instrument.  Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously 

## **Basic financial assets** 

Basic financial assets, which include trade and other debtors, amounts due from group undertakings and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost.  Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the charity transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party. 

## **Basic financial liabilities** 

Basic financial liabilities, including trade and other creditors and amounts due to group undertakings are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.  Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.  Financial liabilities are derecognised when, and only when, the charity’s contractual obligations are discharged, cancelled, or they expire. 

## **(m) Short term liquid investments and cash** 

Cash at bank is held to meet short-term cash commitments as they fall due rather than for investment purposes and includes all cash equivalents held in the form of short-term highly liquid investments. Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. 

Page | 27 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 2. **INCOME FROM DONATIONS AND LEGACIES** 

|Charity<br> **2023**<br>2022<br>**£**<br>£<br>Other donors<br>**10**<br>120<br>Grants – Pfizer grant<br>**19,521**<br>16,213<br>Grants, including EU Tech Project<br>**14,168**<br>15,232<br>Legacies<br>**59,564**<br>**-**<br>3.<br>**INCOME FROM INVESTMENTS**<br> Charity<br> **2023**<br>2022<br>**£**<br>£<br>Interest receivable<br>**2,327**<br>381<br>4.<br>**INCOME FROM** **SUBSCRIPTIONS AND ROYALTIES**<br>Subscription Income:<br>Deferred balance brought forward<br>Membership income received during the year<br>Deferred balance carried forward<br>Royalty income on subscriptions<br>5.<br>**ANNUAL MEETING**<br> Charity<br> <br> **2023**<br>2022<br>**£**<br>£<br>Annual meeting income<br>**-**<br>512,128<br>**93,263**<br> 31,565<br>**2,327**<br>381<br>**-**<br>512,128|Group<br> **2023**<br>2022<br>**£**<br>£<br>**10**<br>120<br>**19,521**<br>16,213<br>**14,168**<br>15,232<br>**59,564**<br>**-**<br>Group<br> **2023**<br>2022<br>**£**<br>£<br> **2,352**<br>381<br>Charity & Group<br>**2023**<br>2022<br>**£**<br>£<br>**7,125**<br>3,922<br>**233,328**<br>212,530<br>**(24,799)**<br>(7,125)<br> **1,153**2,562<br>Group<br> **2023**<br>2022<br>**£**<br>£<br>**220,772**<br>512,128<br> **93,263**<br>31,565<br> **2,352** <br>381<br> **215,654**<br>209,327<br>**216,807 **<br>211,889<br> **220,772** <br>512,128|
|---|---|



Page |28 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 6. **INCOME FROM EDUCATIONAL ACTIVITES** 

|<br>Other income<br>7.<br>**ANALYSIS OF CHARITABLE EXPENDITURE**<br>**Educational Publication &**<br>**Activities Membership**<br>**£**<br>**£**<br>Annual meeting expenses<br>-<br>**-**<br>Journal and other membership costs<br>**-**<br>**1,367**<br>Travel and subsistence costs<br>**2,385**<br>**2,385**<br>Advertising and promotional events<br>**3,240**<br>-<br>Publication committee costs<br>**-**<br>**-**<br>Education committee costs<br>**4,711**<br>**-**<br>Awards, grants and fellowships<br>**26,081**<br>-<br>Educational activity costs**8,241**<br>-<br>Printing and postage costs<br>**22**<br>**22**<br>Staff costs<br>**139,582**<br>**207,995**<br>Finance costs<br>**6,282**<br>**6,282**<br>Trustees’ board costs<br>**-**<br>**-**<br>Support costs (see note 8)<br>**21,640**<br>**21,639**<br>Governance costs (see note 8)<br>**46,428**<br>**46,428**<br>**Charity total**<br>Annual meeting expenses<br>**-**<br>**-**<br>**Group total**<br>**258,612**<br>**286,118**<br> <br>**258,612**<br>**286,118**|<br>**Annual**<br>**meeting**<br>**£**<br>**-**<br>**-**<br>**-**<br>-<br>**-**<br>**-**<br>-<br>-<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||Charity<br>**2023**<br>**£**<br> **609**<br>**Total**<br>**2023**<br>**£**<br>**-**<br>**1,367**<br>**4,770**<br>**3,240**<br>**-**<br>**4,711**<br>**26,081**<br>**8,241**<br>**44**<br>**347,577**<br>**12,564**<br>**-**<br>**43,279**<br>**92,856**<br>**104,721**<br>**649,451**<br>**609** <br>**544,730**|Charity<br>**2023**<br>**£**<br> **609**<br>**Total**<br>**2023**<br>**£**<br>**-**<br>**1,367**<br>**4,770**<br>**3,240**<br>**-**<br>**4,711**<br>**26,081**<br>**8,241**<br>**44**<br>**347,577**<br>**12,564**<br>**-**<br>**43,279**<br>**92,856**<br>**104,721**<br>**649,451**<br>**609** <br>**544,730**|& Group<br>2022<br>£<br>4,564<br>Total<br>2022<br>£<br>370,101<br>1,131<br>2,888<br>179<br>8,500<br>-<br>10,664<br>1,053<br>606<br>403,031<br>7,122<br>6,690<br>54,407<br>77,099<br>77,455<br>1,020,926<br>4,564<br>943,471|
|---|---|---|---|---|---|
|||||||
|||<br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br>||||
||**104,721**<br>**-**|||||
||**104,721**|||||



Page | 29 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 8. **ANALYSIS OF GOVERNANCE AND SUPPORT COSTS** 

Charity & Group 

|**Educational Publication &**<br>**Activities Membership**<br>**Costs**<br>**Costs**<br>**£**<br>**£**<br>**Support costs:**<br>Phone<br>**6,941**<br>**6,941**<br>Insurance<br>**882**<br>**882**<br>Rent, rates, light and heat<br>**5,968**<br>**5,967**<br>Sundry<br>**7,771**<br>**7,772**<br>Amortisation<br>**77**<br>**77**<br>**Governance costs:**<br>Trustees’ board costs<br>**-**<br>**-**<br>Indemnity insurance<br>**135**<br>**135**<br>Staff costs<br>**34,168              34,167**<br>Independent examiner’s fee (see note 11)<br>**3,780**<br>**3,780**<br>Legal and professional<br>**8,345**<br>**8,345**<br>**21,639**<br>**21,639**<br>**46,428**<br>**46,427**|**Total**<br>**2023**<br>**£**<br>**13,882**<br>**1,764**<br>**11,935**<br>**15,543**<br>**154**<br>**-**<br>**270**<br>**68,335**<br>**7,560**<br>**16,690**<br>**43,278**<br>**92,855**|Total<br>2022<br>£<br>12,975<br>1,024<br>14,085<br>26,168<br>155<br>173<br>269<br> 51,723<br>10,800<br>14,134<br>54,407<br>77,099|
|---|---|---|



Support and governance costs have been allocated evenly between educational activities and publication and membership costs. 

## 9. **TRUSTEES REMUNERATION** 

The trustees neither received nor waived any emoluments during the period (2022: £Nil). 

Out of pocket expenses were reimbursed to trustees as follows: 

|Charity & Group<br>**2023**<br>2022<br>**Number**<br>Number<br>Travel and meeting expenses<br>**6**<br>11<br>10.<br>**STAFF COSTS**<br>Charity<br>**2023**<br>2022<br> <br> **£**<br>£<br>Wages and salaries<br>**338,420**<br>364,651<br> <br>National insurance contributions<br>**33,702**<br>38,666<br>Pension contributions<br>**39,890**<br>46,817<br>Recruitment and training<br>**3,900**<br>4,620<br>**415,912**<br>454,754|Charity & Group<br>**2023**<br>2022<br>**£**<br>£<br>**4,105**<br>4,020<br>Group<br>**2023**<br>2022<br>**£**<br>£<br>**338,420**<br>364,651<br>**33,702**<br>38,666<br>**39,890**<br>46,817<br>**3,900**<br>4,620<br>**415,912**<br>454,754|Charity & Group<br>**2023**<br>2022<br>**£**<br>£<br>**4,105**<br>4,020<br>Group<br>**2023**<br>2022<br>**£**<br>£<br>**338,420**<br>364,651<br>**33,702**<br>38,666<br>**39,890**<br>46,817<br>**3,900**<br>4,620<br>**415,912**<br>454,754|
|---|---|---|
|||454,754|



Two employees earned more than £60,000 during the year. 

Page | 30 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 10. **STAFF COSTS - continued** 

The average monthly number of employees, and full time equivalents, during the year were as follows: 

|||Charity|Group|||
|---|---|---|---|---|---|
||**2023**|2022|**2023**|2022||
||**Number**|Number|**Number**|Number||
|Governance|**4.15**|4.7|**4.15**||4.7|
|Educational activities|**3.15**|3.7|**3.15**||3.7|
|Publication and membership|**0.7**|0.6|**0.7**||0.6|
||**8**|9|**8**||9|



The key management personnel of the group and the charity comprise the trustees, the administrative director and the I.T. director. The total employee benefits of the key management personnel of the group were £199,658 (2022: £190,030). 

## 11. **INDEPENDENT EXAMINER’S REMUNERATION** 

The independent examiner’s remuneration consists of the following: 

|For independent examination<br>For accounting services<br>For preparation of consolidated accounts<br>For general advice, meetings & other services|Charity<br>**2023**<br>2022<br> <br>**£**<br>£<br>**1,678**<br>2,550<br>**3,152**<br>4,650<br>**1,780**<br>2,750<br>**950**<br>850<br>**7,560**<br>10,800|Group<br> **2023**<br>2022<br>**£**<br>£<br>**1,678**<br>2,550<br>**7,352**<br>7,450<br>**1,780**<br>2,750<br>**950**<br>850<br>**11,760**<br>13,600|Group<br> **2023**<br>2022<br>**£**<br>£<br>**1,678**<br>2,550<br>**7,352**<br>7,450<br>**1,780**<br>2,750<br>**950**<br>850<br>**11,760**<br>13,600|
|---|---|---|---|
||||13,600|



Page |31 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 12. **CHARITY & CONSOLIDATED INTANGIBLE FIXED ASSETS** 

|**CHARITY & CONSOLIDATED INTANGIBLE FIXED ASSETS**|||
|---|---|---|
|**COST**<br>At 1 January 2023<br>At 31 December 2023<br>**AMORTISATION**<br>At 1 January 2023<br>Charge for year<br>At 31 December 2023<br>**NET BOOK VALUE**<br>At 31 December 2023<br>At 31 December 2022<br>**CONSOLIDATED TANGIBLE FIXED ASSETS**<br>Fixtures<br>and fittings<br>–––––––––<br>**£**<br>**COST:**<br>At 1 January 2023<br>**13,052**<br>Additions<br>**396**<br>––––––<br>At 31 December 2023<br>**13,448**<br>––––––<br>**DEPRECIATION**<br>At 1 January 2023<br>**12,306**<br>Charge for year<br>**539**<br>––––––<br>At 31 December 2023<br>**12,845**<br>––––––<br>**NET BOOK VALUE:**<br>At 31 December 2023<br>**603**<br>At 31 December 2022<br>746|Domain<br>name<br>£<br>**3,106**<br>**1,707** <br>**155**<br>**1,244**<br> <br>1,399<br>Computer<br>equipment<br>–––––––––<br>–––<br>**£**<br>**61,242**<br>**1,228**<br> <br>––––––<br>**62,470**<br>––––––<br>**56,410**<br>**2,285**<br>––––––<br>**58,695**<br> <br>––––––<br>**3,775**<br>4,832<br> **3,106**<br>**1,862**|Totals<br>£<br>**3,106**<br> **3,106**|
|||**1,707**<br>**155**|
|||**1,862 **|
|||**1,244**|
|||1,399<br>Total<br>––––––<br>**£**<br>**74,294**<br>**1,624**<br>––––––<br>**75,918**<br>––––––<br>**68,716**<br>**2,824**<br>––––––<br>**71,540**<br>––––––<br>**4,378**<br>5,578|



## 13. **CONSOLIDATED TANGIBLE FIXED ASSETS** 

Page |32 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 14. **CHARITY FIXED ASSET INVESTMENTS** 

|**COST OR VALUATION:**<br>At 1 January 2023<br>Increase in market value of investments<br>At 31 December 2023<br>**NET BOOK VALUE:**<br>At 31 December 2023<br>At 31 December 2022<br>Listed investments<br>Unlisted investments<br>Total investments|**2023**<br>**£**<br>**759,199**<br>**1**<br>**759,200**|£<br>**754,013**<br>**5,186**<br>**759,199**<br>**759,199**<br>754,013<br>2022<br>£<br>754,013<br>1|
|---|---|---|
|||754,014|



The charity’s investments at the balance sheet date in the share capital of unlisted companies include the following: 

## **Conticom - ICS Limited** 

|Company number: 03687688<br>Country of incorporation: England & Wales<br>Nature of business: Conference facilitator<br>Class of shares: Ordinary – 100% holding<br>Aggregate capital and reserves<br>Profit/(loss) for the year<br>**Results and net assets/(liabilities) of Conticom – ICS Limited**<br>Turnover:<br>Annual meeting income<br>Cost of sales<br>Gross profit<br>Other income<br>Administrative expenses<br>Operating profit/(loss)<br>Finance costs and depreciation<br>Net income/(expenditure)<br>Retained profit for the year<br>Retained profit brought forward<br>Retained profit/(loss)carried forward<br>Assets<br>Liabilities|**2023**<br>**£**<br>**36,342**<br>**70,860**|2022<br>£<br>(34,518)<br>(22,464)<br>£<br>**220,773**<br>**(52,935)**<br>**167,838**<br>**25**<br>**(92,873)**<br>**74,990**<br>**(4,130)**<br>**70,860**<br>**70,860**<br> **(34,519)**<br>**36,341**<br>**48,313**<br>(**11,971)**|
|---|---|---|



Page | 33 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 15. **DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** 

|Trade debtors<br>Prepayments and accrued income<br>Amounts due from group undertaking<br>Other debtors|Charity<br>**2023**<br>2022<br>**£**<br>£<br>**30**<br>57<br>**8,600**<br>33,543<br>**-**<br>63,521<br>**-**<br>2,214<br>_______<br>_______<br>**8,630**<br>99,335|Group<br>**2023**<br>2022<br>**£**<br>£<br>**9,504**<br>57<br>**13,106**<br>35,614<br>**-**<br>-<br>**-**<br>2,214<br>_______<br>_______<br>**22,610**<br>37,885|
|---|---|---|



## 16. **CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** 

|<br>Trade creditors<br>Other creditors<br>Social security and other taxes<br>Amounts due to group undertaking<br>Accruals and deferred income<br>VAT|Charity<br>**2023**<br>2022<br>**£**<br>£<br>**1,086**<br>1,388<br>**-**<br>-<br>**13,703**<br>15,633<br>**12,521**<br>-<br>**67,598**<br>32,624<br>-<br>-<br>_______<br>_______<br>**94,908**<br>49,645|Group<br>**2023**<br>2022<br>**£**<br>£<br>**1,635**<br>2,269<br>**2,797**<br>2,404<br>**13,703**<br>15,633<br>**-**<br>-<br> **75,946**<br>55,630<br>**277**<br>109<br>_______<br>_______<br>**94,358**<br>76,045|
|---|---|---|



## 17. **FINANCIAL COMMITMENTS** 

Total financial commitments, guarantees and contingencies for the charity which are not included in the balance sheet amount to £15,000 (2022 - £Nil). 

Total financial commitments, guarantees and contingencies undertaken as a group, which are not included in the balance sheet amount to £30,000 (2022 - £Nil). 

Page |34 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 18. **STATEMENT OF FUNDS** 


**----- Start of picture text -----**<br>
|||||||||
|---|---|---|---|---|---|---|---|
|At 01|Gains|At 31|
|January|on|December|
|2023|Income Expenditure Investments|2023|
|£|£|£|£|£|
|Unrestricted funds:|
|General fund|962,024|338,702|(508,487)|5,186|797,425|
|-------------- --------------|------------- -------------- --------------|
|Total unrestricted funds|962,024|338,702|(508,487)|5,186|797,425|
|-------------- -------------- -------------- -------------- --------------|
|Restricted funds:|
|Laborie Fellowship fund|1,838                    -             (1,838)|-|-|
|Continence Promotion Committee fund|7,824|-|(7,824)|-|-|
|3|[rd]|World Fistula work|500|-|-|-|500|
|Pfizer grant|7,060|19,521|(26,581)|-|-|
|-------------- --------------    -------------- -------------- --------------|
|Total restricted funds|17,222|19,521|(36,243)|-|500|
|-------------- -------------- -------------- -------------- --------------|
|Total charity funds|979,246|358,223|(544,730)            5,186|797,925|
|-------------- --------------|------------- -------------- --------------|
|Subsidiary funds (unrestricted)|(34,519)|220,798|(149,938)|-|36,341|
|Intercompany adjustment|-|(45,217)|45,217|-|-|
|Total consolidated funds|944,727|533,804|(649,451)|5,186|834,266|
|========= ========= ========= ========= =========|
|STATEMENT OF FUNDS - comparatives|
|At 01|Losses|At 31|
|January|on|December|
|2022|Income Expenditure Investments|2022|
|£|£|£|£|£|
|Unrestricted funds:|
|General fund|1,183,416|744,314|(935,307)|(30,399)|962,024|
|-------------- --------------|------------- -------------- --------------|
|Total unrestricted funds|1,183,416|744,314|(935,307)|(30,399)|962,024|
|-------------- -------------- -------------- -------------- --------------|
|Restricted funds:|
|Laborie Fellowship fund|8                   -               1,830|-               1,838|
|Continence Promotion Committee fund|7,824|-|-|-|7,824|
|3|[rd]|World Fistula work|500|-|-|-|500|
|Pfizer grant|841|16,213|(9,994)|-|7,060|
|-------------- -------------- -------------- -------------- --------------|
|Total restricted funds|9,173|16,213|(8,164)|-|17,222|
|-------------- -------------- -------------- -------------- --------------|
|Total charity funds|1,192,589|760,527|(943,471)|-|979,246|
|-------------- --------------|------------- -------------- --------------|
|Subsidiary funds (unrestricted)|(12,054)|54,991|(77,455)|-|(34,518)|
|Intercompany adjustment|-|-|-|-|-|
|Total consolidated funds|1,180,535|815,518|(1,020,926)|(30,399)|944,728|
|========= ========= ========= ========= =========|

**----- End of picture text -----**<br>


Page |35 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 18. **STATEMENT OF FUNDS - continued** 

## **General fund (unrestricted)** 

This fund represents the free funds of the charity, which are not designated for particular purposes. 

## **Laborie Fellowship fund (restricted)** 

The Laborie Fellowship fund relates to a 3 year fellowship programme for an eligible member. Grants are received each year to support funding of the programme. 

## **Continence Promotion Committee Fund (restricted)** 

The Continence Promotion Committee fund was established to support the activities of the Continence Promotion Committee. 

## **3[rd] World Fistula work (restricted)** 

This fund relates to a restricted donation received in November 2012 to fund 3[rd] world Fitsula work. 

## **Pfizer grant (restricted)** 

This fund relates to a Pfizer grant received each year to fund international scholarships. 

## **Fistula course fund (restricted)** 

This fund relates to a grant received during the year to support the Fistula repair course held in Mumbai. 

## 19. **ANALYSIS OF NET FUNDS BETWEEN FUNDS** 

|**ANALYSIS OF NET FUNDS BETWEEN FUNDS**||||
|---|---|---|---|
||**Restricted**|**Unrestricted**|**Total**|
|**CHARITY**|**Funds**|<br>**Funds**|**Funds**|
||**£**|**£**|**£**|
|**Fund Balances at 31 December 2023**||||
|**are represented by:**||||
|Fixed assets|**-**|**760,444**|**760,444**|
|Current assets|**36,743**|**95,646**|**132,389**|
|Current liabilities|**(36,243)**|**(58,665)**|**(94,908)**|
||–––––––|––––––––|––––––––|
|**Total Net Assets**|**500**|**797,425**|**797,925**|
||**Restricted**|**Unrestricted**|**Total**|
|**GROUP**|**Funds**|<br>**Funds**|**Funds**|
||**£**|**£**|**£**|
|**Fund Balances at 31 December 2023**||||
|**are represented by:**||||
|Fixed assets|**-**|**764,821**|**764,821**|
|Current assets|**36,743**|**127,060**|**163,803**|
|Current liabilities|**(36,243)**|**(58,115)**|**(94,358)**|
||–––––––|––––––––|––––––––|
|**Total Net Assets**|**500**|**833,766**|**834,266**|



Page | 36 



## **THE INTERNATIONAL CONTINENCE SOCIETY** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 

## 19. **ANALYSIS OF NET FUNDS BETWEEN FUNDS – comparatives** 

||Restricted|Unrestricted|Total|
|---|---|---|---|
|**CHARITY**|Funds|<br>Funds|Funds|
||£|£|£|
|**Fund Balances at 31 December 2022**||||
|**are represented by:**||||
|Fixed assets|-|755,413|755,413|
|Current assets|25,386|248,092|273,478|
|Current liabilities|(8,164)|(41,481)|(49,645)|
||–––––––|––––––––|––––––––|
|**Total Net Assets**|17,222|962,024|979,246|
||Restricted|Unrestricted|Total|
|**GROUP**|Funds|<br>Funds|Funds|
||£|£|£|
|**Fund Balances at 31 December 2022**||||
|**are represented by:**||||
|Fixed assets|-|760,990|760,990|
|Current assets|25,386|234,397|259,783|
|Current liabilities|(8,164)|(67,881)|(76,045)|
||_______|________|________|
|**Total Net Assets**|17,222|927,506|944,728|



## 20. **PENSION COMMITMENTS** 

During the year, the group paid into a defined contribution pension scheme.  The total for the year of £39,890 (2022: £46,816) is included within expenditure in the Statement of Financial Activities. 

There were outstanding group contributions of £Nil (2022 - £Nil) as at 31 December 2023. 

## 21. **TAXATION** 

As a registered charity the International Continence Society is exempt from taxation of income and gains falling within Section 505 Taxes Act 1988 or Section 256 Taxation of Chargeable Gains Act 1992 to the extent these are applied to its charitable objects.  No tax charge has arisen during the year.  No tax charge has arisen in the subsidiary as its profits are donated by way of Gift Aid to the charity. 

## 22. **RELATED PARTY TRANSACTIONS** 

There are no related party transactions that require disclosure (2022 - £Nil) as at 31 December 2023. 

Page | 37